SIMCERE PHARMA(02096.HK) will spend HKD 22.21 million to repurchase 1.88 million shares on Jan 20, 2026
SIMCERE PHARMA(02096.HK) released an announcement on Jan 20, 2026, stating that on Jan 20, 2026 it will spend HKD 22.21 million to repurchase 1.88 million shares, repurchase price per share is HKD 11.5945 - HKD 11.9046.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
- SIMCERE PHARMA(02096.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 828.72 million, YoY increase of 37.88%
- SIMCERE PHARMA (02096.HK): Zhu Da appointed Joint Company Secretary succeeding Wan Yushan, waiver granted from company secretary qualification requirements
- SIMCERE PHARMA (02096.HK): First-in-Class Innovative Drug Xibi Xin® (Edaravone and Dexborneol) Included in 2026 National Essential Medicines List
- SIMCERE PHARMA(02096.HK): PD-1/VEGF Bispecific Antibody SIM0689 Approved for Clinical Trials by NMPA
- SIMCERE PHARMA (02096.HK): SIM0613 (LRRC15 ADC) Receives NMPA Clinical Trial Approval
